XORTX Therapeutics
XRTX
4 hedge funds and large institutions have $161M invested in XORTX Therapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.
1,688,184% more capital invested
Capital invested by funds: $9.51K → $161M (+$161M)
33% more funds holding
Funds holding: 3 → 4 (+1)
27.64% more ownership
Funds ownership: 0% → 27.64% (+28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$40.8M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$15.1K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.67K |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$3.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$286 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| $161M | +$40.8M | +552,418 | New |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| $2.66K | +$15.1K | +205 | +788% |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$7.67K | +104 | +10,400% |
|
|
CA
4
Clearstead Advisors
Cleveland,
Ohio
| $640 | +$3.17K | +43 | +358% |
|
|
5
Bank of America
Charlotte,
North Carolina
| – | -$1 | – | – |
|
|
6
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$286 | – | – |
|
XRTX Hedge Fund Activity: Q4 2023 in Review
4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in XORTX Therapeutics (XRTX) for Q4 2023, worth a combined $161M — up 1,688,184% from $9.51K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new XRTX positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was DekaBank Deutsche Girozentrale, opening a new position worth an estimated $40.8M. The largest seller was Toronto Dominion Bank, cutting an estimated $286.
- 4 institutional investors held XORTX Therapeutics (XRTX) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $161M of XORTX Therapeutics stock for Q4 2023, up 1,688,184% quarter-over-quarter.
- 1 fund opened new XORTX Therapeutics positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest XORTX Therapeutics buyer in Q4 2023 was DekaBank Deutsche Girozentrale, an estimated $40.8M added.
- The largest XORTX Therapeutics seller in Q4 2023 was Toronto Dominion Bank, an estimated $286 sold.
Based on aggregated 13F filings for Q4 2023.